SELLAS Life Sciences Group, Inc. - Common Stock (SLS) stock analysis

SLS · SELLAS Life Sciences Group, Inc. - Common Stock

Latest recorded price: USD 7.47

Sector and industry: Healthcare · Biotechnology

Fiscal 2023 figures: revenue growth -100.0%. The model flags 1 risk signal for this company (1 high severity).

Similar companies in Healthcare